HPV DNA Pap Test Approved As Primary Screen; New Guidelines Expected
This article was originally published in The Gray Sheet
Executive Summary
Digene is evaluating various methods of marketing its human papillomavirus (HPV) test to ob/gyn physicians following expanded approval for primary cervical cancer screening March 31
You may also be interested in...
ACOG Updated Cervical Screening Guidelines Include Digene DNAwithPap
Revised cervical cancer screening guidelines from the American College of Obstetricians & Gynecologists could facilitate adoption of Digene's recently approved DNAwithPap test for primary screening
ACOG Updated Cervical Screening Guidelines Include Digene DNAwithPap
Revised cervical cancer screening guidelines from the American College of Obstetricians & Gynecologists could facilitate adoption of Digene's recently approved DNAwithPap test for primary screening
Digene Physician Detailing Pact With PDI Tops DNAwithPap Launch Strategy
Digene does not plan to extend a co-promotion pact with Cytyc for its DNAwithPap test after signing on PDI to set up a U.S. physician detailing organization